Search Results
Dec 19, 2025, 10:28 ET Ingresaron 9 billones de dólares en activos a ADGM mientras la Abu Dhabi Finance Week redefine los flujos de capital a nivel mundial
Ltd., Galaxy Digital y Animoca Asset Management están afianzando una mayor parte de su actividad desde el ADGM.Otro anuncio de RIQ, propiedad de IHC, informó que planea asociarse con Swiss Re, uno de los principales proveedores de seguros y reaseguros del mundo, para promover soluciones de reaseguro
More news about: ADGM
Dec 19, 2025, 10:17 ET 9 trilhões de dólares em ativos comprometidos com o ADGM enquanto a Semana de Finanças de Abu Dhabi redefine os fluxos de capital globais
Internet MEA Ltd., Galaxy Digital e Animoca Asset Management estão concentrando mais de suas atividades no ADGM.A RIQ, empresa pertencente à IHC, anunciou mais uma novidade: sua intenção de firmar parceria com a Swiss Re, uma das principais provedoras de resseguros e seguros do mundo, para desenvolver
More news about: ADGM
Dec 19, 2025, 08:33 ET 阿布札比金融週 (Abu Dhabi Finance Week) 重新定義全球資本流動，9 兆美元資產承諾投入阿布札比全球市場 (ADGM)
宣佈於阿布札比開設中東首間辦公室；而 Hashed Global Management Ltd.、Circle Internet MEA Ltd.、Galaxy Digital 及 Animoca Asset Management 等公司，則正將更多業務活動轉移至阿布札比全球市場 (ADGM) 作為營運樞紐。由 IHC 擁有的 RIQ 另一個公告，該公司表示正計劃與世界領先的再保險和保險提供商之一 Swiss Re 合作，從 ADGM 基地提高風險、數據和由 AI 驅動的再保險解決方案。JPMorgan 通過 ADGM 擴大其支付和庫務服務業務，將使該公司能夠為該當地客戶提供多種解決方案，包括流動性管理和多種貨幣支付功能。如欲查看更多資料，請瀏覽：
More news about: ADGM
Dec 18, 2025, 23:43 ET 9 Billionen US-Dollar Vermögenswerte für ADGM, während Abu Dhabi Finance Week globale Kapitalströme neu definiert
Galaxy Digital sowie Animoca Asset Management mehr Aktivitäten von ADGM aus steuern.Eine weitere Ankündigung von RIQ, das sich im Besitz von IHC befindet, besagt, dass RIQ plant, mit Swiss Re, einem der weltweit führenden Rückversicherungs- und Versicherungsanbieter, zusammenzuarbeiten, um Risiko-,
More news about: ADGM
Dec 18, 2025, 14:04 ET Se comprometen 9 billones de dólares en activos para ADGM
Internet MEA Ltd., Galaxy Digital y Animoca Asset Management están consolidando una mayor actividad desde ADGM.Otro anuncio de RIQ, propiedad de IHC, indica que planea asociarse con Swiss Re, uno de los principales proveedores de reaseguros y seguros del mundo, para impulsar soluciones de reaseguro
More news about: ADGM
Dec 18, 2025, 09:25 ET USD 9 Trillion in Assets Commit to ADGM as Abu Dhabi Finance Week Redefines Global Capital Flows
Circle Internet MEA Ltd., Galaxy Digital and Animoca Asset Management are anchoring more of their activity from ADGM.Another announcement from IHC-owned RIQ, which said it plans to partner with Swiss Re, one of the world's leading reinsurance & insurance providers, to advance risk, data and
More news about: ADGM
Dec 18, 2025, 09:13 ET USD 9 Trillion in Assets Commit to ADGM as Abu Dhabi Finance Week Redefines Global Capital Flows
Circle Internet MEA Ltd., Galaxy Digital and Animoca Asset Management are anchoring more of their activity from ADGM.Another announcement from IHC-owned RIQ, which said it plans to partner with Swiss Re, one of the world's leading reinsurance & insurance providers, to advance risk, data and
More news about: ADGM
Dec 15, 2025, 14:58 ET Roche receives FDA approval for first diagnostic tests to identify HER2-positive metastatic breast cancer patients eligible for ENHERTU
platforms.The assay standardizes all IHC processes from baking through staining, and reduces the possibility of human error.5 It also minimizes inherent variability resulting from individual reagent dilution and other processes found in manual and semi-automated IHC methods. The HER2 (4B5) clone
More news about: Roche
Dec 15, 2025, 09:00 ET Lunit Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Biomarker Discovery and Translational Oncology Research
Collaboration to leverage Lunit SCOPE IO ® and SCOPE universal IHC® (uIHC) digital pathology products in two Daiichi Sankyo oncology research and development programsSEOUL, South Korea, Dec. 15, 2025 /PRNewswire/
More news about: Lunit
Dec 11, 2025, 18:02 ET Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants
criteriaVaccine was safe and well tolerated at the MTD, with adverse events primarily injection-site irritationPreliminary Immunohistochemistry (IHC) of primary tumors showed aLA expression ranging from absent to strong; analyses correlating expression to immune response and clinical outcomes are
More news about: Anixa Biosciences, Inc.
Dec 11, 2025, 13:22 ET Wobble Genomics To Present New Data At SABCS Confirming Platform's Ability To Determine Detailed Profiling of HER2 Status in Tissue and Blood
status with high fidelity from breast cancer tissue, providing detailed isoform-level profiles, and show a correlation with HER2 immunohistochemistry (IHC) scores. The study also establishes the potential of Wobble's long-read RNA technology to determine HER2 targeted therapy selection from blood.These
More news about: Wobble Genomics
Dec 10, 2025, 14:26 ET La Fondation ADI annonce le lancement du réseau principal ADI Chain et du jeton utilitaire ADI
lancer les déploiements sur la chaîne.L'un des premiers projets phares d'ADI Chain sera un stablecoin adossé au dirham, développé par FAB et IHC dans le cadre réglementaire des Émirats arabes unis. Le stablecoin adossé au dirham sert de preuve de concept national conçu spécifiquement pour les
More news about: ADI Foundation
Dec 10, 2025, 14:12 ET ADI 基金會宣佈推出 ADI Chain 主網及 ADI 實用型代幣
鏈，讓全球機構能在不犧牲互操作性、擴展性或安全性的前提下，根據司法管轄區或行業要求推出定制應用程式，從而推動現實世界的採用。基金會已與超過 20 個國家及 50 家主要機構建立合作夥伴關係，覆蓋範圍達 5 億人口。隨著主網啟動，這些合作夥伴將開始遷移試點項目並啟動鏈上部署。ADI Chain 的首批旗艦項目之一，是由 FAB 和 IHC 在阿聯酋監管框架內開發的迪拉姆掛鈎穩定幣。該迪拉姆穩定幣作為專為阿聯酋設計的國家級概念驗證，旨在展示受監管穩定幣如何在國家的法律及金融體系內運作。這亦構成了 ADI Chain 長遠願景的基石，即建立一個多貨幣環境，讓各國能在共享、可互操作且政策一致的基礎設施上發行其主權數碼貨幣，在維護貨幣主權的同時，實現更高效的跨境流動性。支撐此基礎設施的是
More news about: ADI Foundation
Dec 10, 2025, 14:12 ET ADI Foundation kündigt Start des Mainnets von ADI Chain und des ADI Utility Token an
On-Chain-Implementierungen beginnen.Eines der ersten Vorzeigeprojekte auf ADI Chain wird eine durch den Dirham gestützte Stablecoin sein, die von FAB und IHC im Rahmen der Regulierungsvorschriften der VAE entwickelt wird. Die durch den Dirham gestützte Stablecoin dient als nationaler Proof of Concept, der
More news about: ADI Foundation
Dec 10, 2025, 14:03 ET ADI Foundation anuncia el lanzamiento de la red principal de ADI Chain y el token de utilidad ADI
en cadena.Uno de los primeros proyectos emblemáticos de ADI Chain será una stablecoin respaldada por el dirham que están desarrollando FAB e IHC dentro del marco regulatorio de los Emiratos Árabes Unidos. La stablecoin respaldada por el dirham sirve como prueba de concepto nacional diseñada específicamente
More news about: ADI Foundation
Dec 10, 2025, 13:58 ET ADI Foundation anuncia o lançamento da mainnet da ADI Chain e do token utilitário ADI
implantações on-chain.Um dos primeiros projetos de destaque na ADI Chain será uma stablecoin lastreada em dirham, desenvolvida pela FAB e pela IHC dentro do marco regulatório dos Emirados Árabes Unidos. A stablecoin lastreada em dirham serve como uma prova de conceito nacional projetada especificamente
More news about: ADI Foundation
Dec 09, 2025, 14:54 ET ADI Foundation anuncia el lanzamiento de la red principal de ADI Chain y el token de utilidad ADI
implementaciones en cadena.Uno de los primeros proyectos emblemáticos de ADI Chain será una stablecoin respaldada en dírhams, desarrollada por FAB e IHC dentro del marco regulatorio de los EAU. Esta stablecoin, respaldada en dírhams, sirve como prueba de concepto nacional, diseñada específicamente para
More news about: ADI Foundation
Dec 09, 2025, 14:40 ET Borr Drilling Limited - Announces Pricing of Additional Senior Secured Notes Offering
Dec. 9, 2025 /PRNewswire/ -- Borr Drilling Limited (NYSE: BORR) (the "Company") announced today that its wholly owned subsidiary Borr IHC Limited and certain other subsidiaries have priced an offering of additional 10.375% senior secured notes due 2030 (the "Additional Notes") for gross
More news about: Borr Drilling Limited
Dec 09, 2025, 10:21 ET ADI Foundation Announces Launch of ADI Chain's Mainnet and ADI Utility Token
initiating onchain deployments.One of the first flagship projects on ADI Chain will be a Dirham-backed stablecoin being developed by FAB and IHC within the UAE's regulatory framework. The Dirham-backed stablecoin serves as a national proof of concept designed specifically for the UAE demonstrating
More news about: ADI Foundation
Dec 09, 2025, 10:17 ET ADI Foundation Announces Launch of ADI Chain's Mainnet and ADI Utility Token
onchain deployments.One of the first flagship projects on ADI Chain will be a Dirham-backed stablecoin being developed by FAB and IHC within the UAE's regulatory framework. The Dirham-backed stablecoin serves as a national proof of concept designed specifically for the
More news about: ADI Foundation
Dec 04, 2025, 08:30 ET Caris Life Sciences to Showcase 19 Studies at the 2025 San Antonio Breast Cancer Symposium
George W. Sledge, Jr., MD, Caris EVP and Chief Medical Officer. "By integrating whole exome and whole transcriptome sequencing with IHC profiling and AI-driven signatures, we are uncovering new insights into therapeutic resistance and real-world outcomes that bring us closer to truly
More news about: Caris Life Sciences
Dec 02, 2025, 16:05 ET Jazz Pharmaceuticals to Present Pivotal Phase 3 Results of Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma at the 2026 ASCO Gastrointestinal Cancers Symposium
vivo.16 In the United States, Ziihera is indicated for the treatment of adults with previously treated, unresectable or metastatic HER2-positive (IHC 3+) BTC, as detected by an FDA-approved test.16 The U.S. FDA granted accelerated approval for this indication based on overall response rate and duration
More news about: Jazz Pharmaceuticals plc
Dec 02, 2025, 04:00 ET Antengene Announces IND Approval in China for Phase Ib/II Study of ATG-022 (CLDN18.2 ADC) in Combination with KEYTRUDA® (Pembrolizumab) ± Chemotherapy
frontline setting. In addition, antitumor activity was observed across high, medium, and low CLDN18.2 expression levels, supporting the use of IHC 1+ ≥1% as the enrollment threshold for frontline combination therapy, indicating potential applicability to a much broader patient population compared
More news about: Antengene Corporation Limited
Nov 19, 2025, 21:56 ET Antengene Hosts 2025 R&D Day Showcasing Encouraging Clinical Data and Solid Progress with Investigational Programs
Latest data from the Phase I/II CLINCH study: As of November 10, 2025, in patients with moderate to high CLDN18.2 expression (IHC 2+ > 20%), the 2.4 mg/kg dose cohort achieved an objective response rate (ORR) of 40% (12/30), a disease control rate (DCR) of 90% (27/30), and
More news about: Antengene Corporation Limited
Nov 17, 2025, 06:00 ET Positive HERIZON-GEA-01 Phase 3 Results Support Ziihera® (zanidatamab-hrii) as HER2-Targeted Agent-of-Choice and Ziihera Combination Regimens as New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma
metastatic HER2+ GEA (adenocarcinomas of the stomach or esophagus, including the gastroesophageal junction), defined as 3+ HER2 expression by IHC or 2+ HER2 expression by IHC with ISH positivity per central assessment. Patients were randomized to the three trial arms: Ziihera in combination with chemotherapy
More news about: Jazz Pharmaceuticals plc